(Q41561770)

3 October 2017

1 reference

title

Cellular immunotherapy and autologous transplantation for hematologic malignancy (English)

1 reference

3 October 2017

1 reference

2

Negrin RS

1 reference

3 October 2017

K. A. Margolin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9255634

11 November 2024

K. K. Wong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9255634

11 November 2024

S. Chatterjee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9255634

11 November 2024

C. Wright

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9255634

11 November 2024

S. J. Forman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9255634

11 November 2024

language of work or name

1 reference

1 June 1997

1 reference

3 October 2017

June 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9255634

full work available at URL

11 November 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1997.tb00986.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-065X.1997.tb00986.x

11 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

11 November 2024

published in

Immunological Reviews

1 reference

3 October 2017

volume

157

1 reference

3 October 2017

page(s)

231-240

1 reference

Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Induction of CL100 protein tyrosine phosphatase following transient forebrain ischemia in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

A subset of natural killer cells in peripheral blood displays a mature T cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

A severe combined immunodeficiency mutation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Dendritic cells presenting tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Influenza A virus-specific H-2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/Udorn/72.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Proliferating dendritic cell progenitors in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB00986.X

Does interleukin-2 have a role in the management of acute leukemia?

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Lymphokine activated killing of fresh human leukaemias

11 November 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Lymphokine-activated killer (LAK) cells inhibit the clonogenic growth of human leukemic stem cells

11 November 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin

11 November 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study

11 November 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma

11 November 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy

11 November 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

11 November 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells

11 November 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression

11 November 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

T-cell immunity to the joining region of p210BCR-ABL protein

11 November 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide

11 November 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

The dendritic cell system and its role in immunogenicity

11 November 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Induction of TH1 and TH2 immunity in neonatal mice.

11 November 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells

11 November 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.

11 November 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

11 November 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells

11 November 2024

67

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells

11 November 2024

68

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins

11 November 2024

69

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein

11 November 2024

72

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.

11 November 2024

73

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1997.TB00986.X

11 November 2024

Identifiers

1 reference

3 October 2017

1 reference